These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

707 related articles for article (PubMed ID: 21122489)

  • 1. The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Current management.
    Dignass A; Van Assche G; Lindsay JO; Lémann M; Söderholm J; Colombel JF; Danese S; D'Hoore A; Gassull M; Gomollón F; Hommes DW; Michetti P; O'Morain C; Oresland T; Windsor A; Stange EF; Travis SP;
    J Crohns Colitis; 2010 Feb; 4(1):28-62. PubMed ID: 21122489
    [No Abstract]   [Full Text] [Related]  

  • 2. European evidence based consensus on the diagnosis and management of Crohn's disease: current management.
    Travis SP; Stange EF; Lémann M; Oresland T; Chowers Y; Forbes A; D'Haens G; Kitis G; Cortot A; Prantera C; Marteau P; Colombel JF; Gionchetti P; Bouhnik Y; Tiret E; Kroesen J; Starlinger M; Mortensen NJ;
    Gut; 2006 Mar; 55 Suppl 1(Suppl 1):i16-35. PubMed ID: 16481629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The state of the art on treatment of Crohn's disease.
    Shi HY; Ng SC
    J Gastroenterol; 2018 Sep; 53(9):989-998. PubMed ID: 29980848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antagonist: Crohn's disease recurrence can be prevented after ileal resection.
    Rampton DS
    Gut; 2002 Aug; 51(2):153-4. PubMed ID: 12117871
    [No Abstract]   [Full Text] [Related]  

  • 5. Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 2: current management.
    Dignass A; Lindsay JO; Sturm A; Windsor A; Colombel JF; Allez M; D'Haens G; D'Hoore A; Mantzaris G; Novacek G; Oresland T; Reinisch W; Sans M; Stange E; Vermeire S; Travis S; Van Assche G
    J Crohns Colitis; 2012 Dec; 6(10):991-1030. PubMed ID: 23040451
    [No Abstract]   [Full Text] [Related]  

  • 6. The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Special situations.
    Van Assche G; Dignass A; Reinisch W; van der Woude CJ; Sturm A; De Vos M; Guslandi M; Oldenburg B; Dotan I; Marteau P; Ardizzone A; Baumgart DC; D'Haens G; Gionchetti P; Portela F; Vucelic B; Söderholm J; Escher J; Koletzko S; Kolho KL; Lukas M; Mottet C; Tilg H; Vermeire S; Carbonnel F; Cole A; Novacek G; Reinshagen M; Tsianos E; Herrlinger K; Oldenburg B; Bouhnik Y; Kiesslich R; Stange E; Travis S; Lindsay J;
    J Crohns Colitis; 2010 Feb; 4(1):63-101. PubMed ID: 21122490
    [No Abstract]   [Full Text] [Related]  

  • 7. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review.
    Molodecky NA; Soon IS; Rabi DM; Ghali WA; Ferris M; Chernoff G; Benchimol EI; Panaccione R; Ghosh S; Barkema HW; Kaplan GG
    Gastroenterology; 2012 Jan; 142(1):46-54.e42; quiz e30. PubMed ID: 22001864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Guidelines for the management of inflammatory bowel disease in adults.
    Mowat C; Cole A; Windsor A; Ahmad T; Arnott I; Driscoll R; Mitton S; Orchard T; Rutter M; Younge L; Lees C; Ho GT; Satsangi J; Bloom S;
    Gut; 2011 May; 60(5):571-607. PubMed ID: 21464096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 1: definitions and diagnosis.
    Dignass A; Eliakim R; Magro F; Maaser C; Chowers Y; Geboes K; Mantzaris G; Reinisch W; Colombel JF; Vermeire S; Travis S; Lindsay JO; Van Assche G
    J Crohns Colitis; 2012 Dec; 6(10):965-90. PubMed ID: 23040452
    [No Abstract]   [Full Text] [Related]  

  • 10. Epidemiology and natural history of inflammatory bowel diseases.
    Cosnes J; Gower-Rousseau C; Seksik P; Cortot A
    Gastroenterology; 2011 May; 140(6):1785-94. PubMed ID: 21530745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crohn's disease.
    Baumgart DC; Sandborn WJ
    Lancet; 2012 Nov; 380(9853):1590-605. PubMed ID: 22914295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn's Disease 2016: Part 1: Diagnosis and Medical Management.
    Gomollón F; Dignass A; Annese V; Tilg H; Van Assche G; Lindsay JO; Peyrin-Biroulet L; Cullen GJ; Daperno M; Kucharzik T; Rieder F; Almer S; Armuzzi A; Harbord M; Langhorst J; Sans M; Chowers Y; Fiorino G; Juillerat P; Mantzaris GJ; Rizzello F; Vavricka S; Gionchetti P;
    J Crohns Colitis; 2017 Jan; 11(1):3-25. PubMed ID: 27660341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vedolizumab as induction and maintenance therapy for Crohn's disease.
    Sandborn WJ; Feagan BG; Rutgeerts P; Hanauer S; Colombel JF; Sands BE; Lukas M; Fedorak RN; Lee S; Bressler B; Fox I; Rosario M; Sankoh S; Xu J; Stephens K; Milch C; Parikh A;
    N Engl J Med; 2013 Aug; 369(8):711-21. PubMed ID: 23964933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A global consensus on the classification, diagnosis and multidisciplinary treatment of perianal fistulising Crohn's disease.
    Gecse KB; Bemelman W; Kamm MA; Stoker J; Khanna R; Ng SC; Panés J; van Assche G; Liu Z; Hart A; Levesque BG; D'Haens G; ;
    Gut; 2014 Sep; 63(9):1381-92. PubMed ID: 24951257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Consensus guidelines of ECCO/ESPGHAN on the medical management of pediatric Crohn's disease.
    Ruemmele FM; Veres G; Kolho KL; Griffiths A; Levine A; Escher JC; Amil Dias J; Barabino A; Braegger CP; Bronsky J; Buderus S; Martín-de-Carpi J; De Ridder L; Fagerberg UL; Hugot JP; Kierkus J; Kolacek S; Koletzko S; Lionetti P; Miele E; Navas López VM; Paerregaard A; Russell RK; Serban DE; Shaoul R; Van Rheenen P; Veereman G; Weiss B; Wilson D; Dignass A; Eliakim A; Winter H; Turner D; ;
    J Crohns Colitis; 2014 Oct; 8(10):1179-207. PubMed ID: 24909831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. European consensus on the histopathology of inflammatory bowel disease.
    Magro F; Langner C; Driessen A; Ensari A; Geboes K; Mantzaris GJ; Villanacci V; Becheanu G; Borralho Nunes P; Cathomas G; Fries W; Jouret-Mourin A; Mescoli C; de Petris G; Rubio CA; Shepherd NA; Vieth M; Eliakim R; ;
    J Crohns Colitis; 2013 Nov; 7(10):827-51. PubMed ID: 23870728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Environmental risk factors for inflammatory bowel diseases: a review.
    Ananthakrishnan AN
    Dig Dis Sci; 2015 Feb; 60(2):290-8. PubMed ID: 25204669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. British Dietetic Association evidence-based guidelines for the dietary management of Crohn's disease in adults.
    Lee J; Allen R; Ashley S; Becker S; Cummins P; Gbadamosi A; Gooding O; Huston J; Le Couteur J; O'Sullivan D; Wilson S; Lomer MC;
    J Hum Nutr Diet; 2014 Jun; 27(3):207-18. PubMed ID: 24313460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Budesonide for induction of remission in Crohn's disease.
    Rezaie A; Kuenzig ME; Benchimol EI; Griffiths AM; Otley AR; Steinhart AH; Kaplan GG; Seow CH
    Cochrane Database Syst Rev; 2015 Jun; 2015(6):CD000296. PubMed ID: 26039678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Doubling the infliximab dose versus halving the infusion intervals in Crohn's disease patients with loss of response.
    Katz L; Gisbert JP; Manoogian B; Lin K; Steenholdt C; Mantzaris GJ; Atreja A; Ron Y; Swaminath A; Shah S; Hart A; Lakatos PL; Ellul P; Israeli E; Svendsen MN; van der Woude CJ; Katsanos KH; Yun L; Tsianos EV; Nathan T; Abreu M; Dotan I; Lashner B; Brynskov J; Terdiman JP; Higgins PD; Chaparro M; Ben-Horin S
    Inflamm Bowel Dis; 2012 Nov; 18(11):2026-33. PubMed ID: 22294554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.